BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25685621)

  • 21. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.
    Topaz N; Caugant DA; Taha MK; Brynildsrud OB; Debech N; Hong E; Deghmane AE; Ouédraogo R; Ousmane S; Gamougame K; Njanpop-Lafourcade BM; Diarra S; Fox LM; Wang X
    EBioMedicine; 2019 Mar; 41():488-496. PubMed ID: 30846392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
    Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
    J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.
    Traoré Y; Njanpop-Lafourcade BM; Adjogble KL; Lourd M; Yaro S; Nacro B; Drabo A; Parent du Châtelet I; Mueller JE; Taha MK; Borrow R; Nicolas P; Alonso JM; Gessner BD
    Clin Infect Dis; 2006 Oct; 43(7):817-22. PubMed ID: 16941360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.
    Chiou CS; Liao JC; Liao TL; Li CC; Chou CY; Chang HL; Yao SM; Lee YS
    BMC Infect Dis; 2006 Feb; 6():25. PubMed ID: 16478548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The meningitis outbreak returns to Niger: Concern, efforts, challenges, and recommendations.
    Sibomana O; Hakayuwa CM
    Immun Inflamm Dis; 2023 Jul; 11(7):e953. PubMed ID: 37506148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carriage rates and risk factors during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C ST-11 (cc11) in Tuscany, Italy: a cross-sectional study.
    Miglietta A; Innocenti F; Pezzotti P; Riccobono E; Moriondo M; Pecile P; Nieddu F; Rossolini GM; Azzari C; ; Balocchini E; Rezza G; Voller F; Stefanelli P
    BMC Infect Dis; 2019 Jan; 19(1):29. PubMed ID: 30621624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of invasive meningococcal isolates in Burkina Faso as the relative importance of serogroups X and W increases, 2008-2012.
    Retchless AC; Congo-Ouédraogo M; Kambiré D; Vuong J; Chen A; Hu F; Ba AK; Ouédraogo AS; Hema-Ouangraoua S; Patel JC; Traoré RO; Sangaré L; Wang X
    BMC Infect Dis; 2018 Jul; 18(1):337. PubMed ID: 30021533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field evaluation of two rapid diagnostic tests for Neisseria meningitidis serogroup A during the 2006 outbreak in Niger.
    Rose AM; Gerstl S; Mahamane AE; Sidikou F; Djibo S; Bonte L; Caugant DA; Guerin PJ; Chanteau S
    PLoS One; 2009 Oct; 4(10):e7326. PubMed ID: 19802392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
    Alonso JM; Bertherat E; Perea W; Borrow R; Chanteau S; Cohet C; Dodet B; Greenwood B; LaForce FM; Muros-Le Rouzic E; Teyssou R; Ouédraogo-Traoré R; Sow I
    Bull Soc Pathol Exot; 2006 Dec; 99(5):404-8. PubMed ID: 17253061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
    Munguambe AM; de Almeida AECC; Nhantumbo AA; Come CE; Zimba TF; Paulo Langa J; de Filippis I; Gudo ES
    PLoS One; 2018; 13(8):e0197390. PubMed ID: 30089105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.
    Djibo S; Njanpop Lafourcade BM; Boisier P; Moussa A; Kobo G; Sidikou F; Hien A; Bieboure G; Aguilera JF; Parent du Chatelet I; Gessner BD; Chanteau S
    Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):573-8. PubMed ID: 16406096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
    Jackson LA; Schuchat A; Reeves MW; Wenger JD
    JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OUTBREAK OF CEREBROSPINAL MENINGITIS IN KEBBI STATE, NIGERIA.
    Gana GJ; Badung S; Bunza AU; Gidado S; Nguku P
    Ann Ib Postgrad Med; 2017 Jun; 15(1):23-28. PubMed ID: 28970767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987-2013.
    Husain EH; Barakat M; Al-Saleh M
    J Infect Public Health; 2015; 8(5):441-7. PubMed ID: 25779346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.